Mestag Therapeutics

Northern Biologics

This company develops antibody-based therapeutics targeting the tumour microenvironment to treat patients with cancer and fibrosis.

Macomics

The company develops macrophage-modulating antibody therapies and precision medicines for patients with cancer and fibrotic diseases.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Advesya

This biotech company develops immunotherapies and antibody-drug conjugates targeting IL-1RAP for patients with cancer and autoimmune diseases.

Spica Therapeutics

This biotechnology firm develops monoclonal antibody therapies that target pathogenic macrophage subsets to treat patients with cancer and fibroinflammatory diseases.